 |  |  |
| | | |
Mansoor M. Amiji
Anil Patri
Nanomedicine design, development and translation into clinical trials in Oncology- An industrial perspective
Nanoparticle Therapeutics: From Concept to Clinic
Innovation that Enables the Encapsulation of Sparingly Soluble Drugs for Delivery in Liposomes
Evaluation of Pyrrolobenzodiazepine loaded Nanoparticles : A potential targeted drug delivery approachSymposium Sessions | ||
Monday May 14 | ||
| 10:30 | Cancer Nanotechnology | |
| 1:30 | Cancer Therapy & Diagnostics Delivery | |
Tuesday May 15 | ||
| 4:00 | Diagnostics & Bioimaging: Posters | |
| 4:00 | Cancer Nanotechnology: Poster | |
Symposium Program | ||
Monday May 14 | ||
| 10:30 | Cancer Nanotechnology | 252 A |
| Session chair: Anil Patri, U.S. Food & Drug Administration, US | ||
| 10:30 | Nanoparticle Therapeutics: From Concept to Clinic (invited presentation) M.E. Davis, California Institute of Technology, US | |
| 10:55 | Nanomedicine design, development and translation into clinical trials in Oncology- An industrial perspective (invited presentation) S. Puri, AstraZeneca, UK | |
| 11:20 | Cancer Nanotechnology (invited presentation) A. Patri, U.S. Food & Drug Administration, US | |
| 11:45 | Overcoming Challenges in Manufacturing Scale-Up of Plasmonic Gold Nanorods: Bringing Photothermal Therapy to the Clinic. L. Pagliaro, Siva Therapeutics Inc, US | |
| 12:05 | Numerical investigation of Electric field, Ion Transport and pH damage during Electrochemical Treatment of Tumors: Effects of physicochemical reactions and chlorine bleaching A. Mokthare, S.K. Reddy, E.P. Furlani, University at Buffalo, US | |
| 1:30 | Cancer Therapy & Diagnostics Delivery | 252 A |
| Session chair: Anil Patri, U.S. Food and Drug Administration, US; Steve Zullo, NIBIB/NIH, US | ||
| 1:30 | Innovation that Enables the Encapsulation of Sparingly Soluble Drugs for Delivery in Liposomes (invited presentation) F.C. Szoka, C.O. Noble, M.E. Hayes, University of California, San Francisco, US | |
| 1:55 | MRI-Guided Focused Ultrasound: A Transformative, State-of-the-Art Technology for 21st Century Medicine (invited presentation) P. Anastasiadis, University of Maryland School of Medicine, US | |
| 2:20 | Evaluation of Pyrrolobenzodiazepine loaded Nanoparticles : A potential targeted drug delivery approach (invited presentation) P. Tyagi, MedImmune, US | |
| 2:45 | Silver nanoparticles for use in precision medicine-based cancer therapies J. Swanner, C.D. Fahrenholtz, P.-A. Vidi, K.L. Cook, M. McMahon, I. Tenvooren, B.W. Bernish, J.J. Sears, G.L. Donati, R.N. Singh, Wake Forest School of Medicine, US | |
| 3:05 | Functional Polylactide-based Systems for Delivery of Cancer Therapeutics C. Cheng, H. Sun, Y. Yu, C-K Chen, J. Zou, University at Buffalo, the State University of New York, US | |
| 3:25 | In vitro and In vivo evaluation of 2-amino-7(8)-fluorophenazine N5,N10-dioxide within polymeric micelles as theranostic agents N. Lecot, Centro de Investigaciones Nucleares. Facultad de Ciencias, Universidad de la República, Montevideo, Uruguay., UY | |
| 3:45 | Paving a Path for the Clinic – Preclinical Characterization of Nanomedicine (invited presentation) M. Scully, Frederick National Laboratory for Cancer Research, US | |
Tuesday May 15 | ||
| 4:00 | Diagnostics & Bioimaging: Posters | Expo Hall |
| Design and synthesis of novel and privileged small Molecules for prevention and treatment of MRSA and polymicrobial infections T.H. Al-Tel, F.I. Al-Marzooq, S. Vunnam, University of Sharjah, AE | ||
| A Cell-Sensory Bioscaffold of Biocompatible Titanate Nanofiber H. Alismail, University of Arkansas, US | ||
| Single Step Copper Loading of Nanoparticles for PET-Imaging R.K. Prud'homme, Princeton University, US | ||
| Preparation and characterization of nanofibers for the wound healing S-K. Lee, S.K. Lim and S-H. Hwang, DGIST, KR | ||
| Hyaluronic acid-cyclodextrin crosslinked nanofibers for medical applications M. Seon-Lutz, A. Hebraud, A-C. Couffin, S. Vignoud, G. Schlatter, CEA-Leti, FR | ||
| Rapid and scalable formulation and radiolabeling of phthalocyanine-based nanoparticles as a platform for targeted PET R.K. Prud'homme, L.Z. Wang, H.D. Lu, B.K. Wilson, S.A. McManus, P.K. Padakanti, A. Alavi, R.H. Mach, Princeton University, US | ||
| Profiling and Maximizing Critical Thinking Readiness in the Workforce F.C. Feucht, Thinking Habitats, US | ||
| Fluorescence Lifetime Trajectory of the Mouse Pre-Implantation Embryopredicts its Viability N. Ma, N.R. de Mochel, T.Y. Yoo, P.D.A. Pham, K. Cho, M.A. Digman, University of California, Irvine, US | ||
| 4:00 | Cancer Nanotechnology: Poster | Expo Hall |
| Cancer Nanotherapy Promted by a Molecular Capsule that Targets the Cell Nucleus Y. Fang, H-C Zhou, Texas A&M University, US | ||
| Graphenoid plates in glioma therapy. M. Grodzik, J. Szczepaniak, B. Strojny, J. Jaworski, M. Wierzbicki, J. Jagiello, E. Soltan, T. Mandat, Warsaw University of Life Sciences (WULS), PL | ||
| Layer-by-Layer Nanoparticles for the Detection and Treatment of Ovarian Cancer N. Boehnke, S. Correa, L. Hao, W. Wang, S. N. Bhatia, P. T. Hammond, Massachusetts Institute of Technology, US | ||
| Cancer Nanotherapy Promted by a Molecular Capsule that Targets the Cell Nucleus Yu Fang, Hong-Cai Zhou, Texas A&M University, US | ||
| Microwave Resonater Treatment by AAO Nano Filter and Nanoflowers Filter for Killing Cancer Cell in Blood Dialysis System N-Y. Kim and E-S. Kim, Kwangwoon University, KR | ||
This symposium will highlight the ways in which nanotechnology can address challenges of cancer detection, diagnosis and therapy. Distinguished speakers will summarize the current state of the art and share the excitement surrounding approaches and materials that will have a revolutionary impact on cancer treatment in the future. Contributions are also solicited in the following topics:
To receive announcements and news, please join our mailing list.
